Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access

Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to TonixOn August 15, 2025, the U.S. Food ...

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access

Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya (cyclobenzaprine ...

US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease

Fortress Biotech on Wednesday said the U.S. Food and Drug Administration declined to approve the drug it is developing with ...
The Bakersfield Californian

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom ...

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tabletsPatients reported high ...